Pressmeddelanden, rapporter och bolagsmeddelande för Curasight
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight Announces Enrollment of First Patient in Phase 2 trial with uTRACE[®] in Prostate Cancer
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight Announces Enrollment of First Patient in Phase 2 trial with uTRACE[®] in Prostate Cancer
Spotlight News
Nyhetsuppdatering från Curasight
Reports: Interim report Q1 2024
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight announces approval of clinical trial application (CTA) for phase 2 trial with uTRACE[®] in prostate cancer patients
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight announces change in the Board of Directors
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight announces change in the Board of Directors
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Resolutions of the Annual General Meeting 2024 of Curasight A/S
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight not to proceed with rights issue; evaluating alternative financing opportunities
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Notice of Annual General Meeting 2024
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: The subscription period in Curasight’s rights issue begins today